Differential proteomic distribution of TTR (pre-albumin) forms in serum and HDL of patients with high cardiovascular risk

Atherosclerosis

Volumn 222, Issue 1, 2012, Pages 263-269

  Cubedo, Judit ^a,b,e   Padró, Teresa ^a,e   Alonso, Rodrigo ^f   Cinca, Juan ^c   Mata, Pedro ^f   Badimon, Lina ^a,b,d,e  

^a Institut Català de Ciències Cardiovasculars   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^f Jimenez Diaz Foundation   (Spain)

Author keywords

Acute myocardial infarction; Cardiovascular risk; Familiar hypercholesterolemia; Proteomic studies; TTR

Indexed keywords

HIGH DENSITY LIPOPROTEIN; PREALBUMIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; RISK ASSESSMENT; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREALBUMIN; PROTEOMICS; RISK FACTORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84859831988     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.024     Document Type: Article

References (31)

1. Thygesen K., Alpert J.S., White H.D. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007, 50:2173-2195.
2. Cho K.H., Shin D.G., Baek S.H., Kim J.R. Myocardial infarction patients show altered lipoprotein properties and functions when compared with stable angina pectoris patients. Exp Mol Med 2009, 41:67-76.
3. Bernstein L.H. Transthyretin and the systemic inflammatory response. Curr Nutr Food Sci 2009, 5:71-74.
4. Johnson A.M., Merlini G., Sheldon J., Ichihara K. Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition. Clin Chem Lab Med 2007, 45:419-426.
5. Ingbar S.H. Pre-albumin: a thyroxinebinding protein of human plasma. Endocrinology 1958, 63:256-259.
6. Goodman D.S., Peters T., Robbins J., Schwick G. Prealbumin becomes transthyretin. J Biol Chem 1981, 256:12-14.
7. Monaco H.L. The transthyretin-retinol-binding protein complex. Biochim Biophys Acta 2000, 1482:65-72. [review].
8. Itoh N., Hanafusa T., Miyagawa J., et al. Transthyretin (prealbumin) in the pancreas and sera of newly diagnosed type I (insulin-dependent) diabetic patients. J Clin Endocrinol Metab 1992, 74:1372-1377.
9. Liu L., Liu J., Dai S., et al. Reduced transthyretin expression in sera of lung cancer. Cancer Sci 2007, 98:1617-1624.
10. Carriere I., Dupuy A.M., Lacroux A., Cristol J.P., Delcourt C. Pathologies Oculaires Liées à l'Age Study Group. Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people. J Am Geriatr Soc 2008, 56:840-846.
11. Sousa M.M., Berglund L., Saraiva M.J. Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J Lipid Res 2000, 41:58-65.
12. Cubedo J., Padró T., García-Moll X., Pintó X., Cinca J., Badimon L. Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction. J Proteome Res 2011, 10:211-220.
13. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008, 54:24-38. [review].
14. Kiernan U.A., Nedelkov D., Nelson R.W. Multiplexed mass spectrometric immunoassay in biomarker research: a novel approach to the determination of a myocardial infarct. J Proteome Res 2006, 5:2928-2934.
15. Schneider F., Hammarström P., Kelly J.W. Transthyretin slowly exchanges subunits under physiological conditions: a convenient chromatographic method to study subunit exchange in oligomeric proteins. Protein Sci 2001, 10:1606-1613.
16. Reixach N., Deechongkit S., Jiang X., Kelly J.W., Buxbaum J.N. Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci USA 2004, 101:2817-2822.
17. Ingenbleek Y., Young V.R. Significance of transthyretin in protein metabolism. Clin Chem Lab Med 2002, 40:1281-1291. [review].
18. Férard G., Gaudias J., Bourguignat A., Ingenbleek Y. C-reactive protein to transthyretin ratio for the early diagnosis and follow-up of postoperative infection. Clin Chem Lab Med 2002, 40:1334-1338.
19. Zanotti G., Berni R. Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin. Vitam Horm 2004, 69:271-295.
20. Bobbert T., Raila J., Schwarz F., et al. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis 2010, 213:549-551.
21. Ingenbleek Y., Bernstein L. The stressful condition as a nutritionally dependent adaptive dichotomy. Nutrition 1999, 15:305-320. [review].
22. Bernstein L.H., Ingenbleek Y. Transthyretin: its response to malnutrition and stress injury. clinical usefulness and economic implications. Clin Chem Lab Med 2002, 40:1344-1348. [review].
23. Friberg L., Drvota V., Bjelak A.H., Eggertsen G., Ahnve S. Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction. Am J Med 2001, 111:699-703.
24. Eber B., Schumacher M., Langsteger W., et al. Changes in thyroid hormone parameters after acute myocardial infarction. Cardiology 1995, 86:152-156.
25. Franklyn J.A., Gammage M.D., Ramsden D.B., Sheppard M.C. Thyroid status in patients after acute myocardial infarction. Clin Sci (Lond) 1984, 67:585-590.
26. Naruko T., Ueda M., Ehara S., et al. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis. Arterioscler Thromb Vasc Biol 2006, 26:877-883.
27. Kojima S., Funahashi T., Otsuka F., et al. Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction. Atherosclerosis 2007, 194:204-213.
28. Tanaka Y., Ando Y., Kumamoto T., et al. Changed affinity of apolipoprotein AII to high density lipoprotein (HDL) in patients with familial amyloidotic polyneuropathy (FAP) type I. Biochim Biophys Acta 1994, 1225:311-316.
29. Miller N.E. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987, 113:589-597. [review].
30. Badimon L., Vilahur G. LDL-cholesterol vs HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution vs thrombotic chaos. Ann NY Acad Sci 2012, 10.1111/j.1749-6632.2012.06480.
31. Davidson W.S., Silva R.A., Chantepie S., Lagor W.R., Chapman M.J., Kontush A. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler Thromb Vasc Biol 2009, 29:870-876.